The O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation status and clinical outcomes of Ewing sarcoma patients treated with irinotecan and temozolomide

BACKGROUND: There remains an unmet need to identify molecular biomarkers in Ewing sarcoma (ES). We sought to assess the influence of the O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation on response and progression-free survival (PFS) following initiation of irinotecan and temozol...

Descripción completa

Detalles Bibliográficos
Autores principales: Salah, Samer, Naser, Walid, Jaber, Omar, Saleh, Yacob, Mustafa, Rawan, Abuhijlih, Ramiz, Abuhijla, Fawzi, Ismaeel, Taleb, Yaser, Sameer, Sultan, Iyad, Mustafa, Nour, Tbakhi, Abdelghani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746634/
https://www.ncbi.nlm.nih.gov/pubmed/36523794
http://dx.doi.org/10.5603/RPOR.a2022.0084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746634/
https://www.ncbi.nlm.nih.gov/pubmed/36523794
http://dx.doi.org/10.5603/RPOR.a2022.0084

Ejemplares similares